Deutsche Bank Ag\ Regeneron Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 539,269 shares of REGN stock, worth $379 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

539,269

Previous 442,940 21.75%

Holding current value

$379 Million

Previous $466 Million 17.5%

% of portfolio

0.16%

Previous 0.19%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $67.6 Million - $101 Million	96,329 Added 21.75%	539,269 $384 Million
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $42.8 Million - $50.2 Million	41,768 Added 10.41%	442,940 $466 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $78.7 Million - $95.4 Million	89,096 Added 28.55%	401,172 $422 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $12 Million - $13.2 Million	-13,319 Reduced 4.09%	312,076 $300 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $41.7 Million - $47.4 Million	53,764 Added 19.79%	325,395 $286 Million
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $19.5 Million - $23.8 Million	-28,150 Reduced 9.39%	271,631 $224 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $2.08 Million - $2.47 Million	-2,971 Reduced 0.98%	299,781 $215 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $14.5 Million - $17.6 Million	-21,286 Reduced 6.57%	302,752 $249 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $858,362 - $931,930	-1,216 Reduced 0.37%	324,038 $234 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $21.6 Million - $27.2 Million	-37,570 Reduced 10.35%	325,254 $224 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $27 Million - $36.3 Million	-49,181 Reduced 11.94%	362,824 $214 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.75 Million - $2.05 Million	-2,936 Reduced 0.71%	412,005 $288 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $18.5 Million - $22.8 Million	-34,017 Reduced 7.58%	414,941 $262 Million
Q3 2021 Nov 04, 2021	SELL	$574.03 - $680.96 $30.3 Million - $35.9 Million	-52,753 Reduced 10.51%	448,958 $272 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $17.7 Million - $20.9 Million	37,449 Added 8.07%	501,711 $280 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $15.4 Million - $18.9 Million	34,491 Added 8.03%	464,262 $220 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $25.3 Million - $32.2 Million	52,914 Added 14.04%	429,771 $208 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $8.35 Million - $10.1 Million	15,336 Added 4.24%	376,857 $211 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $14.7 Million - $19.2 Million	-29,797 Reduced 7.61%	361,521 $225 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $27.7 Million - $40.7 Million	-82,329 Reduced 17.38%	391,318 $191 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $42.6 Million - $58.6 Million	-155,540 Reduced 24.72%	473,647 $178 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $9.09 Million - $10.6 Million	33,249 Added 5.58%	629,187 $175 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $24.8 Million - $34.4 Million	82,934 Added 16.17%	595,938 $187 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $8.53 Million - $10.1 Million	22,918 Added 4.68%	513,004 $211 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $2.28 Million - $2.74 Million	6,798 Added 1.41%	490,086 $183 Million
Q3 2018 Dec 21, 2021	BUY	$351.14 - $408.51 $64.2 Million - $74.7 Million	182,838 Added 60.85%	483,288 $195 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $173 Million - $201 Million	-491,504 Reduced 62.06%	300,450 $121 Million
Q2 2018 Apr 21, 2020	BUY	$284.6 - $344.99 $67.5 Million - $81.8 Million	237,026 Added 42.71%	791,954 $273 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $169 Million - $205 Million	-594,038 Reduced 51.7%	554,928 $191 Million
Q1 2018 Oct 18, 2019	BUY	$315.82 - $393.78 $122 Million - $153 Million	387,493 Added 50.89%	1,148,966 $396 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $70.9 Million - $88.4 Million	224,392 Added 41.78%	761,473 $262 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $97.6 Million - $128 Million	272,122 Added 102.7%	537,081 $202 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $114 Million - $134 Million	264,959	264,959 $118 Million

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account